HIGHLIGHTS
- who: Max A. Skibber from the Department of Pediatric Surgery, McGovern Medical School, University of Texas Health Science Center at Houston, At Houston, Houston, TX, United States have published the research work: Enhancing Mesenchymal Stromal Cell Potency: Inflammatory Licensing via Mechanotransduction, in the Journal: (JOURNAL)
- what: This study builds on the previous work by investigating how a range of physiologic WSS magnitudes Frontiers in Immunology | www.frontiersin.org affect the prospective cell therapy's clinical translatability in a bioreactor scaled up for research purposes. The authors demonstrate a dose-dependence of mesenchymal stromal cells' antiinflammatory . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.